Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAllogene Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Allogene Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Aug 21, 2026Douglas Earl MartinSVP, General Counsel29,697Common Stock$62.1KSell
Jul 1, 2026Roberts ZacharyPresident and CEO476,190Stock Option (Right to buy)$1MGrant / award
Jul 1, 2026Roberts ZacharyPresident and CEO134,530Restricted Stock Unit$286.5KGrant / award
Jun 18, 2026SATO VICKI LDirector95,400Restricted Stock Unit$190.8KGrant / award
Jun 18, 2026Kazam Joshua ADirector95,400Restricted Stock Unit$190.8KGrant / award
Jun 18, 2026Kazam Joshua ADirector47,700Common Stock$95.4KExercise / conversion
Jun 18, 2026Humer Franz BDirector95,400Restricted Stock Unit$190.8KGrant / award
Jun 18, 2026WITTE OWEN N.Director95,400Restricted Stock Unit$190.8KGrant / award
Jun 18, 2026Mayo StephenDirector144,400Stock Option (Right to buy)$288.8KGrant / award
Jun 18, 2026MESSEMER DEBORAH M.Director95,400Restricted Stock Unit$190.8KGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$1.71Close · Sep 22, 2026